7S7A
Crystal structure of CDK2 liganded with compound EF3019
Summary for 7S7A
Entry DOI | 10.2210/pdb7s7a/pdb |
Descriptor | Cyclin-dependent kinase 2, 1,2-ETHANEDIOL, 2-{[2-(2H-indazol-3-yl)ethyl]amino}-5-(trifluoromethyl)benzoic acid, ... (4 entities in total) |
Functional Keywords | allosteric inhibitor, drug development, kinase, cell cycle |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 34512.00 |
Authors | Sun, L.,Schonbrunn, E. (deposition date: 2021-09-15, release date: 2022-09-28, Last modification date: 2024-04-10) |
Primary citation | Faber, E.B.,Wang, N.,John, K.,Sun, L.,Wong, H.L.,Burban, D.,Francis, R.,Tian, D.,Hong, K.H.,Yang, A.,Wang, L.,Elsaid, M.,Khalid, H.,Levinson, N.M.,Schonbrunn, E.,Hawkinson, J.E.,Georg, G.I. Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice. J.Med.Chem., 66:1928-1940, 2023 Cited by PubMed: 36701569DOI: 10.1021/acs.jmedchem.2c01731 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.7 Å) |
Structure validation
Download full validation report